Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Organ-on-a-chip models Over the past decade, the development of a novel technique known as organ-on-a-chip (OOAC) has gained great popularity [262, 263]
Whether it's from overexertion in the gym or an ongoing issue from an injury, BPC 157 helps to reduce inflammation by promoting healing at a cellular level
They were treated with a GLP-1 RA (liraglutide 92.5%, exenatide 6.2%, lixisenatide 0.7%, and dulaglutide 0.6%) or dipeptidyl peptidase 4 inhibitors [57]
You might benefit from Drip & Glow if you: - Notice your skin looking dull or tired - Want to support natural collagen production - Have uneven skin tone or texture - Feel your skincare routine isn't enough - Lead a busy, stressful lifestyle - Want to support your skin from within When topical treatments aren't delivering the results you're after, skin glow IV therapy works from the inside out
FOXO4-DRI Key Research Facts Full name: FOXO4 D-Retro-Inverso peptide (FOXO4-DRI) Classification: Cell-penetrating senolytic peptide FOXO4/p53 protein-protein interaction inhibitor Design: D-retro-inverso isoform of FOXO4s p53-binding domain reversed sequence with all D-amino acids Binding target: p53 transactivation domain 2 (TAD2) displaces FOXO4 from the FOXO4-p53 complex Mechanism: FOXO4-DRI binds p53 TAD2 p53 nuclear exclusion p53 mitochondrial translocation BAX activation caspase-3 cleavage senescent cell-selective apoptosis Selectivity basis: FOXO4 is upregulated in senescent cells but expressed at low levels in most non-senescent adult cells selectivity is mechanistically conferred D-amino acid advantage: Proteolytic stability resistant to intracellular peptidases that would rapidly degrade equivalent L-amino acid sequences Structural characterisation: NMR structural models of FOXO4-DRI/p53TAD2 complex resolved (Nature Communications, 2025) confirms disordered-to-ordered transition upon binding Research cell types studied: IMR90 fibroblasts, TM3 Leydig cells, endothelial cells, chondrocytes, keloid fibroblasts, HCT116 cancer cells In vitro working concentration: 25 M used in multiple published studies for senescent cell apoptosis induction What Does FOXO4-DRI Do in Research
Side effects are generally mild and temporarymostly headache, brief dizziness, or flushing
